This is the text extract for 2010-10 Schedule Dispatch, browse documents here.

---

16 September 2010 October 2010 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the October 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details.

New listings · Loperamide hydrochloride (Diamide Relief) cap 2 mg – up to 30 cap available on a PSO (p’code 2365545) · Imiglucerase (Cerezyme) inj 40 iu per ml, 400 iu vial – Special Authority – Retail pharmacy – Section 29 (p’code 2373165) · Sodium chloride (Pfizer) inj 0.9%, 5 ml (p’code 691941) and 10 ml (p’code 691968) – Up to 5 inj available on a PSO · Deferiprone (Ferriprox) tab 500 mg (p’code 2369532) and oral liq 100 mg per 1 ml, 250 ml OP (p’code 2369524) – Special Authority – Retail pharmacy · Cilazapril (Zapril) tab 0.5 mg (p’code 2354330), 2.5 mg (p’code 2354349) and 5 mg (p’code 2354357) · Adapalene (Differin) crm 0.1%, 30 g OP (p’code 386731), and gel 0.1%, 30 g OP (p’code 456160) – Only on a prescription and maximum of 30 g per prescription · Amoxycillin (Alphamox) cap 250 mg – Up to 30 cap available on a PSO (p’code 2362716) · Amoxycillin (Alphamox) cap 500 mg (p’code 2362724) · Ondansetron (Dr Reddy’s Ondansetron) tab 4 mg (p’code 2369508) and 8 mg (p’code 2369516) – Maximum of 12 tab per prescription and maximum of 6 tab per dispensing – not more than one prescription per month – restrictions can be waived by Special Authority · Erlotinib hydrochloride (Tarceva) tab 100 mg (p’code 2245159) and 150 mg (p’code 2245167) – Retail pharmacy-Specialist – Special Authority · Anastrozole (Aremed) tab 1 mg (p’code 2360799) · Mycophenolate mofetil (Myaccord) tab 500 mg (p’code 2326914) and cap 250 mg (p’code 2346281) – Special Authority – Retail pharmacy · Budesonide (Budenocort) powder for inhalation 200 µg per dose, 200 dose OP (p’code 2360276 ) and 400 µg per dose, 200 dose OP (p’code 2360284) · Chloramphenicol (Chlorafast) eye drops 0.5% (p’code 2368137) · Standard formulae – phenobarbitone sodium paediatric oral liquid (10 mg per ml) · Oral supplement 1kcal/ml (Ensure) powder (chocolate) 900 g OP (p’code 2372576) and (vanilla) 900 g OP (p’code 2372584) – Special Authority – Hospital pharmacy [HP3] · Paediatric oral feed 1kcal/ml (Pediasure) liquid (vanilla) 200 ml OP – Special Authority – Hospital pharmacy [HP3] (p’code 2372630) · Renal oral feed 2kcal/ml (Nepro (strawberry)) liquid 200 ml OP – Special Authority – Hospital pharmacy [HP3] (p’code 2372657) · Enteral feed with fibre 1kcal/ml liquid 237 ml OP (Jevity) (p’code 2372606) and liquid 500 ml OP (Jevity RTH) (p’code 2372592) – Special Authority – Hospital pharmacy [HP3] · Enteral feed 1kcal/ml liquid 250 ml OP (Osmolite) (p’code 2372622) and liquid 500 ml OP (Osmolite RTH) (p’code 2372614) – Special Authority – Hospital pharmacy [HP3] · Enteral feed with fibre 1.5kcal/ml (Ensure Plus HN) liquid 250 ml OP – Special Authority – Hospital pharmacy [HP3] (p’code 2372665) · Elemental formula (Elecare) powder (vanilla) 400 g OP (p’code 2372533) and (unflavoured) 400 g OP (p’code 2372568) and (Elecare LCP) powder (unflavoured) 400 g OP (p’code 2372541) – Special Authority – Hospital pharmacy [HP3]

A381044 Page 1 of 3

---

Changes to restrictions · Sodium chloride (Pharmacia and Multichem) inj 0.9%, 20 ml – addition of Up to 5 inj available on a PSO · Ezetimibe (Ezetrol) tab 10 mg – amended Special Authority criteria · Ezetimibe with simvastatin (Vytorin) tab 10 mg with simvastatin 10 mg, 20 mg, 40 mg and 80 mg – amended Special Authority criteria · Tenofovir disoproxil fumarate (Viread) tab 300 mg – amended Special Authority criteria · Mianserin hydrochloride (Tolvon) tab 30 mg – amended Special Authority criteria · Capecitabine (Xeloda) tab 150 mg and 500 mg – amended Special Authority criteria · Mycophenolate mofetil (Cellcept and Myaccord) tab 500 mg and cap 250 mg – amended Special Authority criteria · Rituximab inj 100 mg per 10 ml vial and inj 500 mg per 50 ml vial (Mabthera), and inj 1 mg for ECP (Baxter) – amended Special Authority criteria · Travoprost (Travatan) eye drops 0.004%, 2.5 ml OP – removal of additional subsidy by endorsement Decreased subsidy Chemical Presentation Fully subsidised brands

Vitala-C Azamun* Imuprine Aspen Ceftriaxone Dapa-Tabs Napamide* Univent, Ipratropium Steri-Neb* A-Lices Tolvon Cellcept*, Myaccord Ovestin Ovestin Ensure Dr Reddy’s Quetiapine, Seroquel*, Quetapel Micolette

Partially subsidised brands

Apo-Ascorbic acid Imuran AFT

Ascorbic acid Azathioprine Ceftriaxone sodium Indapamide Ipratropium bromide Malathion Mianserin hydrochloride Mycophenolate mofetil Oestriol Oral supplement 1 kcal/ml Quetiapine

Tab 100 mg Tab 50 mg Inj 1 g Tab 2.5 mg Nebuliser solution 250 µg per ml, 1 ml and 2 ml Liq 0.5 %, 200 ml OP Tab 30 mg Tab 500 mg and cap 250 mg Crm 1 mg per g with applicator and Pessaries 500 µg Powder (chocolate, strawberry and vanilla) 400 g OP Tab 25 mg, 100 mg, 200 mg and 300 mg Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml Tab 1 mg, 2 mg and 5 mg Purified for iInj 5 ml, 10 ml and 20 ml

Derbac-M

Sodium citrate with sodium lauryl sulphoacetate Terazosin hydrochloride Water purified for inj

Microlax

Arrow Multichem*, Astra Zeneca

Apo-Terazosin

* Where there is more than one brand listed as fully subsidised in the Fully Subsidised Brands column, the brands marked with an asterisk (*) are the brands where the subsidy changes from 1 October 2010.

A381044 Page 2 of 3

---

Increased subsidy Chemical

Nitrofurantoin Sodium chloride Travoprost Urea

Presentation

Tab 50 mg and 100 mg Inj 0.9 %, 20 ml Eye drops 0.004%, 2.5 ml OP Crm 10%, 100 g OP

Fully subsidised brands

Nifuran Multichem Travatan Nutraplus

NB. For further details and magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule.

A381044 Page 3 of 3